• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肠出血性大肠杆菌及其感染:1977年至1995年]

[Enterohemorrhagic Escherichia coli and its infection: from 1977 to 1995].

作者信息

Takede Y

机构信息

Research Institute, International Medical Center of Japan.

出版信息

Nihon Rinsho. 1997 Mar;55(3):635-40.

PMID:9086772
Abstract

In 1997, Konowalchuk and coworkers reported a toxin produced by Escherichia coli that was cytotoxic to Vero cells. This toxin(Vero toxin, VT) was subsequently found to be an important virulence factor of E. coli associated with an outbreak of hemorrhagic colitis due to E. coli O157:H7 which occurred in the state of Oregon and Michigan in US. E. coli O157:H7 was then found to produce VT, which was cross-reactive with Shiga toxin produced by Shigella dysenteriae. VT(Shiga-like toxin Shiga toxin, Shiga toxin family) is the toxin which contributes to the symptoms of hemorrhagic colitis and hemolytic uremic syndrome. This article presents a historical perspective on EHEC and also reviews the structure and function of VT as well as epidemiological aspects of outbreak and sporadic cases of EHEC in American continent and in our county.

摘要

1997年,科诺瓦尔丘克及其同事报告了一种由大肠杆菌产生的对Vero细胞具有细胞毒性的毒素。这种毒素(Vero毒素,VT)随后被发现是大肠杆菌的一种重要毒力因子,与美国俄勒冈州和密歇根州发生的由大肠杆菌O157:H7引起的出血性结肠炎疫情有关。随后发现大肠杆菌O157:H7产生的VT与痢疾志贺菌产生的志贺毒素有交叉反应。VT(类志贺毒素、志贺毒素,志贺毒素家族)是导致出血性结肠炎和溶血尿毒综合征症状的毒素。本文介绍了肠出血性大肠杆菌的历史背景,并综述了VT的结构和功能,以及美洲大陆和我国肠出血性大肠杆菌疫情和散发病例的流行病学情况。

相似文献

1
[Enterohemorrhagic Escherichia coli and its infection: from 1977 to 1995].[肠出血性大肠杆菌及其感染:1977年至1995年]
Nihon Rinsho. 1997 Mar;55(3):635-40.
2
Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.人源肠出血性大肠杆菌O157感染的志贺毒素阴性变异株的流行率、毒力谱及临床意义
Clin Infect Dis. 2007 Jul 1;45(1):39-45. doi: 10.1086/518573. Epub 2007 May 21.
3
Hemorrhagic colitis associated with Escherichia coli O157:H7.与大肠杆菌O157:H7相关的出血性结肠炎
Adv Intern Med. 1992;37:173-95.
4
The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.非O157产志贺毒素大肠杆菌日益凸显的临床重要性。
Clin Infect Dis. 2006 Dec 15;43(12):1587-95. doi: 10.1086/509573. Epub 2006 Nov 9.
5
Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.溶血性尿毒症综合征监测,以监测大肠杆菌O157:H7及其他产志贺毒素大肠杆菌感染的趋势。
Emerg Infect Dis. 1997 Jul-Sep;3(3):409-12. doi: 10.3201/eid0303.970329.
6
Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.溶血尿毒综合征与产志贺毒素大肠杆菌菌株之间的关联。
Rev Latinoam Microbiol. 1998 Jan-Jun;40(1-2):1-8.
7
[Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].肠出血性大肠杆菌与溶血尿毒综合征
Wien Klin Wochenschr. 1997 Sep 19;109(17):669-77.
8
Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic Syndrome.肠出血性大肠杆菌感染和溶血尿毒综合征。
Med Clin North Am. 2013 Jul;97(4):681-95, xi. doi: 10.1016/j.mcna.2013.04.001.
9
The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.丁酸梭菌益生菌治疗对小鼠肠出血性大肠杆菌O157:H7感染的影响。
FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):219-26. doi: 10.1016/j.femsim.2004.03.010.
10
Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.在疾病暴发期间从人类身上分离出的大肠杆菌O157:H7菌株与从健康牛身上分离出的菌株之间的毒力差异。
Appl Environ Microbiol. 2007 Nov;73(22):7338-46. doi: 10.1128/AEM.00755-07. Epub 2007 Sep 21.